Malonyl coenzyme A decarboxylase deficiency with a novel mutation

Area of Science:

• Biochemistry
• Genetics
• Metabolic Disorders

Background:

• Malonyl-CoA is a key intermediate in fatty acid synthesis, regulated by acetyl-CoA carboxylase and Malonyl-CoA decarboxylase (MLYCD).
• MLYCD (E.C.4.1.1.9) catalyzes malonyl-CoA to acetyl-CoA conversion, influencing cytosolic malonyl-CoA levels.
• Genetic defects in MLYCD are linked to metabolic disorders, with 34 cases previously reported.

Purpose of the Study:

• To investigate the genetic basis of malonic aciduria in a patient with neonatal onset.
• To identify and characterize novel mutations within the MLYCD gene.
• To contribute to the understanding of MLYCD gene defects and their clinical implications.

Main Methods:

• Clinical follow-up of a patient diagnosed with malonic aciduria.
• Molecular analysis of the MLYCD gene to detect mutations.
• Genomic sequencing to identify homozygous mutations.

Main Results:

• Identification of novel homozygous mutations in the MLYCD gene in the affected patient.
• Confirmation of MLYCD gene defects as the cause of malonic aciduria.
• Expansion of the known mutational repertoire for the MLYCD gene.

Conclusions:

• The study identifies new MLYCD gene mutations, broadening the understanding of malonic aciduria.
• Novel MLYCD mutations contribute to the genetic diversity of metabolic disorders.
• Further research into MLYCD function and related pathologies is warranted.